F. Hoffmann-La Roche Ltd.

Company Snapshot

Founded: 1896
Entity Type: Public
Employees: 103605
Region: North America
Revenue: $69,753.00 Millions
Revenue Year: 2023
Segment: Diagnostics
Headquarter: Basel, Switzerland
Key Geographics: Europe, North America
Corporate Address: Konzern-Hauptsitz Grenzacherstrasse 124, CH-4070, Basel Switzerland Tel. +41-61-688-1111 www.roche.com

Company Overview

F. Hoffmann-La Roche Ltd. (Roche) develops diagnostic tests and systems for key market segments, including scientific research, clinical laboratory systems and patient self-monitoring. The company’s key business areas are professional diagnostics, diabetes care, molecular diagnostics and tissue diagnostics: focusing on healthcare applications and applied science, which supplies specialty bio chemicals and manufactures research reagents and systems for life sciences research.
 
Roche offers its medical devices and diagnostics through its Roche Diagnostics division. Roche Diabetes Care, a business unit of Roche Diagnostics, manufactures blood glucose monitoring systems including CGM and diabetes management systems and services. The Roche product line encompasses blood glucose meters, lancing devices, data management systems, and insulin drug and delivery devices. 

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

F. Hoffmann-La Roche Ltd. In Reports

Global Thyroid Gland Disorders: Diagnostics and Treatment Market

Our detailed report on the Thyroid Gland Disorder Market trends It includes global revenue ($ Million) for the base year of 2023 and estimated data for the forecast period 2024 through 2029.

Oncology Diagnostics: Global Markets

BCC Research Report: Dive into oncology diagnostics market revenues can be estimated based on the product category, by application, by end user and by region.

Biologic Therapeutic Drugs: Technologies and Global Markets

BCC Research Report: Dive into Biologic Therapeutic Drugs Market report includes global revenue ($ Million) for base year data of 2023 and estimated data for the forecast period 2024 through 2029.

Company's Business Segments

  • Pharmaceuticals : Oncology, Neuroscience, Immunology, Haemophilia A, Ophthalmology. Infectious diseases, Other therapeutic areas
  • Diagnostics : Core Lab, Molecular Lab, Pathology Lab, Point of Care and Diabetes Care

Applications/End User Industries

  • Healthcare
  • Diagnostics
  • Therapeutics
  • Biosystems
  • Laboratories
  • Biotechnology
  • Healthcare Providers
  • Clinical Laboratories
  • Research Institutions
  • Public Health Agencies
  • Life Sciences Research
  • Biomedical Engineering
  • Biopharmaceutical Manufacturing
  • Veterinary Medicine
  • Pharmaceuticals
  • Point-of-Care Settings
  • Healthcare Consumers
  • Forensic Science
  • Healthcare IT and Data Analytics